Trial of NanoDoce Intratumoral Injection in Renal Cell Carcinoma
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT04260360|
Recruitment Status : Withdrawn (Not initiated)
First Posted : February 7, 2020
Last Update Posted : August 4, 2020
US Biotest, Inc.
Information provided by (Responsible Party):
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
|Recruitment Status :||Withdrawn|
|Estimated Primary Completion Date :||June 2022|
|Estimated Study Completion Date :||October 2022|